ZNF814: A Potential Drug Target and Biomarker for Various Diseases
ZNF814: A Potential Drug Target and Biomarker for Various Diseases
ZNF814 (ZN814_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and gastrointestinal tract. It is a member of the ZNF8 gene family, which is known for its role in regulating gene expression and cell proliferation. ZNF814 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, ZNF814 has generated a lot of interest as a potential drug target or biomarker.
One of the key features of ZNF814 is its ability to interact with various signaling pathways. It has been shown to play a role in the signaling pathways that regulate cell proliferation, differentiation, and survival. For example, ZNF814 has been shown to be involved in the signaling pathway known as the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases.
Another feature of ZNF814 is its ability to modulate the activity of various signaling pathways. It has been shown to play a role in the signaling pathways that regulate cell adhesion, migration, and survival. For example, ZNF814 has been shown to interact with the E-cadherin protein, which is involved in cell adhesion and migration. This interaction suggests that ZNF814 may play a role in the regulation of cell migration and the development of various diseases, including cancer.
In addition to its role in signaling pathways, ZNF814 has also been shown to have a direct impact on the structure and function of various cellular components. It has been shown to interact with various proteins, including the transcription factor NF-kappa-B. This interaction suggests that ZNF814 may play a role in the regulation of gene expression and the expression of various diseases.
Given its involvement in various signaling pathways and its ability to modulate the activity of these pathways, ZNF814 has generated a lot of interest as a potential drug target or biomarker. Studies have shown that blocking ZNF814 can lead to a variety of cellular and physiological changes, including the inhibition of cell proliferation, the loss of cellular adhesion and migration, and the regulation of gene expression. These effects make ZNF814 a promising target for the development of various drugs, including anti-cancer agents, anti-neurodegenerative agents, and anti-autoimmune agents.
In addition to its potential as a drug target, ZNF814 has also been shown to be a potential biomarker for various diseases. The regulation of gene expression by ZNF814 has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that the expression of ZNF814 is decreased in various tissues of cancer cells, and that this decrease is associated with the poor prognosis of these diseases.
In conclusion, ZNF814 is a protein that has been shown to play a role in the development and progression of various diseases. Its ability to interact with various signaling pathways and its ability to modulate the activity of these pathways make it a promising target for the development of drugs. Furthermore, its involvement in the regulation of gene expression makes it a potential biomarker for various diseases. Further research is needed to fully understand the role of ZNF814 in the development and progression of various diseases, and to determine its potential as a drug target or biomarker.
Protein Name: Zinc Finger Protein 814
The "ZNF814 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF814 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1 | ZNG1A | ZNG1B | ZNG1C | ZNG1E | ZNG1F | ZNHIT1 | ZNHIT2 | ZNHIT3 | ZNHIT6 | ZNRD2 | ZNRD2-DT | ZNRF1 | ZNRF2 | ZNRF2P1 | ZNRF3 | ZNRF3-AS1 | ZNRF4 | ZP1 | ZP2 | ZP3 | ZP4 | ZPBP | ZPBP2 | ZPLD1 | ZPLD2P | ZPR1 | ZRANB1 | ZRANB2 | ZRANB2-AS1 | ZRANB2-DT | ZRANB3 | ZRS | ZRSR2 | ZRSR2P1 | ZSCAN1 | ZSCAN10 | ZSCAN12 | ZSCAN12P1 | ZSCAN16 | ZSCAN16-AS1 | ZSCAN18 | ZSCAN2 | ZSCAN20 | ZSCAN21 | ZSCAN22 | ZSCAN23 | ZSCAN25 | ZSCAN26 | ZSCAN29 | ZSCAN30
